These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21976574)

  • 1. Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children.
    Coles CL; Seidman JC; Levens J; Mkocha H; Munoz B; West S
    Am J Trop Med Hyg; 2011 Oct; 85(4):691-6. PubMed ID: 21976574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children.
    Coles CL; Levens J; Seidman JC; Mkocha H; Munoz B; West S
    Pediatr Infect Dis J; 2012 Apr; 31(4):341-6. PubMed ID: 22173140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control.
    Seidman JC; Coles CL; Silbergeld EK; Levens J; Mkocha H; Johnson LB; Muñoz B; West SK
    Int J Epidemiol; 2014 Aug; 43(4):1105-13. PubMed ID: 24659584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
    Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
    Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geospatial distribution and clustering of Chlamydia trachomatis in communities undergoing mass azithromycin treatment.
    Yohannan J; He B; Wang J; Greene G; Schein Y; Mkocha H; Munoz B; Quinn TC; Gaydos C; West SK
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4144-50. PubMed ID: 24906862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control.
    West SK; Munoz BE; Mkocha H; Gaydos C; Quinn T
    Ophthalmic Epidemiol; 2015; 22(3):170-5. PubMed ID: 26158574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.
    West SK; Munoz B; Mkocha H; Gaydos CA; Quinn TC
    J Infect Dis; 2011 Jul; 204(2):268-73. PubMed ID: 21673038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics.
    Ervin AM; Mkocha H; Munoz B; Dreger K; Dize L; Gaydos C; Quinn TC; West SK
    Ophthalmic Epidemiol; 2016 Dec; 23(6):347-353. PubMed ID: 27820670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
    Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
    JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term malaria reduction by single-dose azithromycin during mass drug administration for trachoma, Tanzania.
    Schachterle SE; Mtove G; Levens JP; Clemens E; Shi L; Raj A; Dumler JS; Munoz B; West S; Sullivan DJ
    Emerg Infect Dis; 2014 Jun; 20(6):941-9. PubMed ID: 24865642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
    Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
    PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do infants increase the risk of re-emergent infection in households after mass drug administration for trachoma?
    West SK; Stare D; Mkocha H; Munoz B; Gaydos C; Quinn TC
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):6040-2. PubMed ID: 21680866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohort and age effects of mass drug administration on prevalence of trachoma: a longitudinal study in rural Tanzania.
    Shekhawat N; Mkocha H; Munoz B; Gaydos C; Dize L; Quinn TC; West SK
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2307-14. PubMed ID: 24448262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
    Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
    Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting antibiotics to households for trachoma control.
    Blake IM; Burton MJ; Solomon AW; West SK; Basáñez MG; Gambhir M; Bailey RL; Mabey DC; Grassly NC
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e862. PubMed ID: 21072225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin in control of trachoma.
    Schachter J; West SK; Mabey D; Dawson CR; Bobo L; Bailey R; Vitale S; Quinn TC; Sheta A; Sallam S; Mkocha H; Mabey D; Faal H
    Lancet; 1999 Aug; 354(9179):630-5. PubMed ID: 10466664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.
    Fraser-Hurt N; Bailey RL; Cousens S; Mabey D; Faal H; Mabey DC
    Bull World Health Organ; 2001; 79(7):632-40. PubMed ID: 11477966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania.
    Cajas-Monson LC; Mkocha H; Muñoz B; Quinn TC; Gaydos CA; West SK
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e978. PubMed ID: 21423645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.
    Wilson N; Goodhew B; Mkocha H; Joseph K; Bandea C; Black C; Igietseme J; Munoz B; West SK; Lammie P; Kasubi M; Martin DL
    Ophthalmic Epidemiol; 2019 Feb; 26(1):1-6. PubMed ID: 30543311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.